Representation of Women in Randomized Clinical Trials of Cardiovascular Disease Prevention

[1]  Gustavo Saposnik,et al.  Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2014, Stroke.

[2]  J. Fernández-Sáez,et al.  Looking twice at the gender equity index for public health impact , 2013, BMC Public Health.

[3]  Mark D. Huffman,et al.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.

[4]  W. Little,et al.  Sex and cardiovascular risk: are women advantaged or men disadvantaged? , 2012, Circulation.

[5]  C. Carter,et al.  Dialogues on diversifying clinical trials: successful strategies for engaging women and minorities in clinical trials. , 2012, Journal of women's health.

[6]  R. Redberg,et al.  Evaluating sex differences in medical device clinical trials: time for action. , 2012, JAMA.

[7]  E. Barrett-Connor,et al.  Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. , 2011, Circulation.

[8]  S. Phillips.  Including Gender in Public Health Research , 2011, Public health reports.

[9]  M. Saag,et al.  Health-Related Quality of Life in the Gender, Race, And Clinical Experience Trial , 2011, AIDS research and treatment.

[10]  K. Squires,et al.  Recruitment and retention of diverse populations in antiretroviral clinical trials: practical applications from the gender, race and clinical experience study. , 2011, Journal of women's health.

[11]  Rowena J Dolor,et al.  Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. , 2011, Journal of the American College of Cardiology.

[12]  S. Geller,et al.  Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: have we made progress? , 2011, Journal of women's health.

[13]  L. Bero,et al.  Gender Bias in Studies for Food and Drug Administration Premarket Approval of Cardiovascular Devices , 2011, Circulation. Cardiovascular quality and outcomes.

[14]  C. Rudin,et al.  Geographic proximity and racial disparities in cancer clinical trial participation. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

[15]  L. Newby,et al.  Twelve-Year Follow-Up of American Women's Awareness of Cardiovascular Disease Risk and Barriers to Heart Health , 2010, Circulation. Cardiovascular quality and outcomes.

[16]  C. Noel Bairey Merz,et al.  Women and ischemic heart disease: evolving knowledge. , 2009, Journal of the American College of Cardiology.

[17]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[18]  I. Palacios,et al.  Sex Differences in Medical Care and Early Death After Acute Myocardial Infarction , 2008, Circulation.

[19]  P. Douglas,et al.  Improving the quality of care for women with cardiovascular disease: report of a DCRI Think Tank, March 8 to 9, 2007. , 2008, American heart journal.

[20]  M. Lenoir,et al.  The project IMPACT experience to date: increasing minority participation and awareness of clinical trials. , 2008, Journal of the National Medical Association.

[21]  R. Redberg,et al.  Variations between clinical trial participants and Medicare beneficiaries in evidence used for Medicare national coverage decisions. , 2008, Archives of internal medicine.

[22]  E. Pinnow,et al.  Improving Women's Health Through Modernization of Our Bioinformatics Infrastructure , 2008, Clinical pharmacology and therapeutics.

[23]  K. Furie,et al.  Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.

[24]  K. Alexander,et al.  Enoxaparin dosing and associated risk of in-hospital bleeding and death in patients with non ST-segment elevation acute coronary syndromes. , 2007, Archives of internal medicine.

[25]  L. Newby,et al.  Who refuses enrollment in cardiac clinical trials? , 2007, Clinical trials.

[26]  JoAnn E Manson,et al.  Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials. , 2007, Archives of internal medicine.

[27]  Rowena J Dolor,et al.  Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. , 2007, Journal of the American College of Cardiology.

[28]  M. T. Ruiz Cantero,et al.  European Medicines Agency policies for clinical trials leave women unprotected , 2006, Journal of Epidemiology and Community Health.

[29]  A. Elixhauser,et al.  Hospitalizations for Women with Circulatory Disease, 2003 , 2006 .

[30]  Carl J Pepine,et al.  Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. , 2006, Journal of the American College of Cardiology.

[31]  S. Reis,et al.  Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. , 2006, Journal of the American College of Cardiology.

[32]  Gianni Tognoni,et al.  Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men: A Sex-Specific Meta-Analysis of Randomized Controlled Trials , 2006, JAMA.

[33]  T. Thom,et al.  American Heart Association Statistics Committee and Stroke Statistics Subcommittee : Heart disease and stroke statistical-2006 update : A report from the American Heart Association Statistics Committee and Stroke statistics subcommittee , 2006 .

[34]  H. Krumholz,et al.  Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. , 2005, The New England journal of medicine.

[35]  L. Newby,et al.  Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/Ameri , 2005, Journal of the American College of Cardiology.

[36]  Thomas Mills,et al.  National Study of Physician Awareness and Adherence to Cardiovascular Disease Prevention Guidelines , 2005, Circulation.

[37]  M. Pignone,et al.  Drug treatment of hyperlipidemia in women. , 2004, JAMA.

[38]  L. Mosca.  Summary of the American Heart Association’s Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[39]  Constance K Haan,et al.  Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[40]  E. Peterson,et al.  Willingness to participate in cardiac trials. , 2004, The American journal of geriatric cardiology.

[41]  Constance K Haan,et al.  Evidence-based guidelines for cardiovascular disease prevention in women. , 2004, Circulation.

[42]  L. Leape,et al.  Adherence to practice guidelines: the role of specialty society guidelines. , 2003, American heart journal.

[43]  Harlan M Krumholz,et al.  Representation of the elderly, women, and minorities in heart failure clinical trials. , 2002, Archives of internal medicine.

[44]  H. Bosworth,et al.  Are women worrying about heart disease? , 2002, Women's health issues : official publication of the Jacobs Institute of Women's Health.

[45]  J. Rossouw,et al.  Hormones, genetic factors, and gender differences in cardiovascular disease. , 2002, Cardiovascular research.

[46]  R. Califf,et al.  Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials , 2002, The Lancet.

[47]  K. Alexander,et al.  Representation of elderly persons and women in published randomized trials of acute coronary syndromes. , 2001, JAMA.

[48]  Theresa M. Wizemann,et al.  Exploring the biological contributions to human health: does sex matter? , 2001, Journal of women's health & gender-based medicine.

[49]  V. Muller.  Exploring the biological contributions to human health: does sex matter? , 2001, Journal of women's health & gender-based medicine.

[50]  M. Rademaker.  Do Women Have More Adverse Drug Reactions? , 2001, American journal of clinical dermatology.

[51]  David J Harris,et al.  Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute. , 2000, The New England journal of medicine.

[52]  J. Robbins,et al.  Gender differences in the utilization of health care services. , 2000, The Journal of family practice.

[53]  D. Cook,et al.  The trials and tribulations of clinical practice guidelines. , 1999, JAMA.

[54]  R. Grol,et al.  Preventing recurrent coronary heart disease , 1998 .

[55]  A. U. Rickel,et al.  Guidelines for Prevention, I , 1998 .

[56]  R. Grol,et al.  Preventing recurrent coronary heart disease. We need to attend more to implementing evidence based practice. , 1998, BMJ.

[57]  D. Herrington,et al.  Long-term (5-year) changes in HDL cholesterol in cardiac rehabilitation patients. Do sex differences exist? , 1995, Circulation.

[58]  J. Avorn,et al.  The exclusion of the elderly and women from clinical trials in acute myocardial infarction. , 1992, JAMA.